Related Experiment Video
Updated: Jul 4, 2026

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
Published on: June 9, 2017
Insights into signaling from the beta2-adrenergic receptor structure
1Department of Biochemistry, Institute for Research in Immunology and Cancer, Groupe de Recherche Universitaire sur le Médicament, Université de Montréal, CP 6128 Succursale Centre-Ville, Montréal, Québec H3C 3J7, Canada.
The beta(2)-adrenergic receptor structure reveals differences from rhodopsin, offering insights into drug binding and signaling. This allows for predicting how drug structures influence receptor responses.
Area of Science:
- Biochemistry
- Structural Biology
- Pharmacology
Background:
- G protein-coupled receptors (GPCRs) are a vast family of membrane proteins crucial for cellular signal transduction.
- High-resolution 3D structures were limited, with only rhodopsin known until recently.
- The beta(2)-adrenergic receptor is a key GPCR involved in various physiological processes.
Purpose of the Study:
- To analyze the structural differences between the newly resolved beta(2)-adrenergic receptor and rhodopsin.
- To investigate the binding modes of diffusible ligands within the receptor.
- To formulate hypotheses on structural determinants linking drug binding to signaling outcomes.
Main Methods:
- Obtained high-resolution three-dimensional crystal structure of the beta(2)-adrenergic receptor.
- Performed virtual docking of ligands with distinct activities using the receptor structure.
- Correlated ligand binding modes with their known efficacy profiles.
Main Results:
- The beta(2)-adrenergic receptor structure exhibits significant differences compared to rhodopsin.
- Virtual docking revealed distinct ligand binding modes that correlate with their efficacy.
- These findings suggest a link between ligand binding conformation and downstream signaling.
Conclusions:
- The structural insights from the beta(2)-adrenergic receptor can elucidate ligand-receptor interactions.
- It is possible to predict structural determinants governing drug signaling efficacies.
- This research opens avenues for structure-based drug design targeting GPCRs.
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Sympathetic Signaling
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...

